Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin versus dual antiplatelet therapy in minor acute ischemic stroke after intravenous thrombolysis
IRCT20230729058953N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing Aspirin monotherapy with Dual antiplatelet therapy (aspirin + clopidogrel) (2 arms). Started Aug 2023; status: completed.
02
Drugs
aspirinclopidogrel
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20230729058953N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230729058953N1.